News Brexit could marginalise UK life sciences - expert Cancer doctor concerned over impact on life sciences R&D.
News Vasopharm drug could limit damage caused by brain injuries German biotech moves into phase 3 after a long wait
News Novartis move damages CAR-T confidence Swiss pharma axes gene therapy unit, causing investor angst.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
